2015;15:789 - 97. Montanide ISA 51 VG. SEPPIC. Investigator’s brochure, 2015. Morán A, Ortega P, de Juan C, et al. Differential colorectal carcinogenesis: Molecular basis and clinical relevance. World J Gastrointest Oncol. 2010;2:151 -8. Mulé MP, Mannis GN, Wood BL, et al. Multigene measurable residual disease assessment pmproves acute myeloid leukemia relapse risk stratification in autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2016;22:1974 -82. SELLAS Life Sciences Group Galinpepimut -S Protocol : SLS17 -201/ MK3475 -770 Protocol v1.1 (Amendment 1.0) 12 April 2019 Page 247 Müller L, Knights A, and Pawelec G. Synthetic peptides derived from Wilms’ tumor 1 protein sensitize human T lymphocytes to recognize chronic myelogenous leukemia cells. Hematol J.